November 9, 2020

BioPharma Dive launches Gene Therapy, Commercialization newsletters

Since 2014, BioPharama Dive has served its readers with our signature in-depth reporting and analysis of drug development, industry dealmaking and now, the search for a coronavirus vaccine.

As we expand and deepen our reporting, we are making two exciting changes to better focus our publications on whats important to our readers.

We have relaunched Manufacturing Weekly as Gene Therapy Weekly. Gene Therapy Weekly will deeply cover the fast-emerging field of genetic medicine, from viral vector gene therapy to CRISPR gene editing and CAR-T cell therapy.

We know manufacturing is crucial for gene therapies, and we'll continue to cover how drugmakers design and build complex treatments. Major manufacturing news that doesn't involve gene therapy will feature in our Daily Dive newsletter.

Sign up for Gene Therapy Weekly here .

Also this week, we rebranded Marketing Weekly as Commercialization Weekly. We believe the new name better reflects the stories we already include in the newsletter, which covers how drugs are approved and sold as well as marketed. We will continue to cover the latest on drug advertising, pharmaceutical and biotech company salesforces, market competition and patent defenses just as our readers have come to expect.

Sign up for Commercialization Weekly here .